InspireMD (NYSEAMERICAN:NSPR) Trading Down 1.6%
InspireMD (NYSEAMERICAN:NSPR) Trading Down 1.6%
InspireMD, Inc. (NYSEAMERICAN:NSPR – Get Rating)'s stock price fell 1.6% on Monday . The company traded as low as $1.79 and last traded at $1.80. 5,429 shares changed hands during trading, a decline of 77% from the average session volume of 23,743 shares. The stock had previously closed at $1.83.
InSpireMD，Inc.(NYSEAMERICAN：NSPR-GET Rating)週一股價下跌1.6%。該公司股價最低跌至1.79美元，最新報1.80美元。交易中有5,429股易手，較23,743股的平均成交量下跌77%。該股此前收盤報1.83美元。
InspireMD Stock Performance
InspirreMD股票表現
The company has a market capitalization of $14.98 million, a price-to-earnings ratio of -0.60 and a beta of 1.51.
該公司市值為1,498萬美元，市盈率為-0.60倍，貝塔係數為1.51。
InspireMD (NYSEAMERICAN:NSPR – Get Rating) last posted its quarterly earnings results on Tuesday, August 9th. The medical equipment provider reported ($0.59) earnings per share for the quarter. InspireMD had a negative return on equity of 43.80% and a negative net margin of 448.33%. The company had revenue of $1.53 million for the quarter.
InSpireMD(NYSEAMERICAN：NSPR-GET Rating)最近一次公佈季度收益結果是在8月9日，星期二。這家醫療設備提供商公佈了本季度每股收益(0.59美元)。InSpireMD的淨資產回報率為負43.80%，淨利潤率為負448.33%。該公司本季度的收入為153萬美元。
Insider Activity at InspireMD
InSpireMD的內幕活動
Institutional Investors Weigh In On InspireMD
機構投資者參與InspirreMD
A hedge fund recently bought a new stake in InspireMD stock. Millennium Management LLC purchased a new stake in InspireMD, Inc. (NYSEAMERICAN:NSPR – Get Rating) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 14,191 shares of the medical equipment provider's stock, valued at approximately $28,000. Millennium Management LLC owned 0.17% of InspireMD as of its most recent filing with the Securities & Exchange Commission. Institutional investors own 2.09% of the company's stock.
一家對衝基金最近購買了InSpireMD股票的新股份。根據千禧管理公司在最近提交給美國證券交易委員會的13F文件中，該公司在第二季度購買了InSpireMD，Inc.(NYSEAMERICAN：NSPR-GET Rating)的新股份。該公司購買了這家醫療設備提供商的14,191股股票，價值約28,000美元。截至最近提交給美國證券交易委員會(Securities&Exchange Commission)的文件，Millennium Management LLC持有InspirreMD 0.17%的股份。機構投資者持有該公司2.09%的股票。
About InspireMD
關於InspirreMD
(Get Rating)
(獲取評級)
InspireMD, Inc, a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system for use in carotid artery applications; and MGuard Prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions, as well as bypass surgery.
InspirreMD公司是一家醫療設備公司，專注於開發專有的MicroNet支架平臺技術並將其商業化，用於治療歐洲、拉丁美洲、中東和亞太地區的血管和冠狀動脈疾病。該公司提供用於頸動脈應用的CGuard頸動脈血栓預防系統，以及用於急性冠脈綜合徵患者的MGuard Prime血栓保護系統，特別是急性心肌梗死、大隱靜脈移植冠狀動脈介入治療以及搭橋手術。
Read More
閲讀更多內容
- Get a free copy of the StockNews.com research report on InspireMD (NSPR)
- 3 Downgraded Must-Have Stocks To Put On Your Watchlist
- This Is What To Expect From The Q3 Earnings Reporting Season
- 3 Biotech Stocks Gaining Momentum
- Can Electronic Arts Buck the Downturn in Videogaming?
- Dollar General is the Big Fish in Little Ponds Across the U.S.
- 免費獲取StockNews.com關於InspirreMD的研究報告(NSPR)
- 3只被降級的必備股票放在你的觀察名單上
- 這是對第三季度收益報告季節的預期
- 3只生物科技股勢頭強勁
- 電子藝界能扭轉電子遊戲市場的低迷嗎？
- 美元將軍是美國小池塘裏的大魚。
Receive News & Ratings for InspireMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InspireMD and related companies with MarketBeat.com's FREE daily email newsletter.
接受《InspirreMD日報》的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對InSpireMD和相關公司的最新新聞和分析師評級的每日簡要摘要。